Daniel Griffin updates the clinical situation with COVID-19 patients, followed by analysis of the remedesivir clinical trial results, and answers listener questions.
Hosts:Vincent RacanielloandRich Condit
Guest:Daniel Griffin
Click arrow to play:
Links for this episode
- Pulmonary embolism in COVID-19 (Emerg Inf Dis) 9:03
- Patch Study 11:43
- Remdesivir in adults with severe COVID-19 (Lancet) 22:31
- ACTT remdesivir trial (NIAID) 34:44
- Commentary on remdesivir trials (Lancet) 28:22
- FDA expected to issue remdesivir EUA (Contagion Live) 39:03
- Recovered COVID-19 patients wrong (Korea Herald) 40:33
- Letters read on TWiV 608 45:24
- Image credit
- Timestamps by Jolene. Thanks!
